Dear readers,
For most of the modern era, we believed depression was slow to treat by nature. You started a medication, you waited four to six weeks, and you hoped. We told patients this so many times it began to feel like a law of physics: the brain heals slowly, if it heals at all. Then a humble surgical anesthetic, in use since the 1960s, quietly overturned that assumption, and in doing so it changed how I think about what the brain is actually capable of.
I’ve been exploring low-dose ketamine in my own practice lately, carefully and with a lot of curiosity, and I wanted to share why I find it one of the more fascinating frontiers in medicine right now.
A different door into the brain
Nearly every antidepressant of the last half-century works on the same handful of chemicals, serotonin chiefly among them. They nudge the brain’s existing machinery and wait for it to adapt. Ketamine does something else entirely. It works on glutamate, the brain’s most abundant signaling molecule, and through it appears to touch the brain’s capacity for neuroplasticity, the ability to grow new connections between neurons.
This is the part I find most intriguing. Chronic stress and depression don’t just make you feel bad; they physically wear the brain down. In imaging studies, the dendrites, the branching arms that neurons use to talk to one another, actually retract and thin in mood-regulating regions. Depression, in a real and visible sense, is a loss of connection inside the brain itself. And what the research suggests about ketamine is almost poetic: within hours, it appears to coax those connections to begin regrowing. Synapses reform. The architecture starts to come back. We’re not just quieting a symptom. We may be helping the brain physically rebuild what was lost.
And it happens fast. The discovery that truly shook psychiatry was speed, relief arriving not in weeks but sometimes within a day. For someone who has been drowning for years, the idea that the water might recede in hours isn’t a minor improvement. It rearranges what we thought was possible.
What the science shows so far
The strongest, most rigorous evidence is for the higher-dose forms, IV ketamine and the FDA-approved nasal spray esketamine, where controlled trials show clear, rapid relief in people who had run out of options. With the low-dose lozenge, the version you can take at home, our understanding is still evolving, but the early signal is real and encouraging. A placebo-controlled trial of oral ketamine in treatment-resistant depression found a roughly 13-point drop in depression scores over three weeks, against about 3 points on placebo, and about a third of patients reached full remission, people for whom nothing else had worked. Pooled across nearly 600 patients, the antidepressant effect holds up, with roughly one in five gaining a benefit they wouldn’t otherwise have had. For PTSD, the early controlled work, mostly intravenous, points in the same hopeful direction.
What we don’t yet have is decades of data on the lowest-dose, daily, at-home model specifically. We’re at the frontier, and frontiers are by their nature still being mapped. Part of what helps patients is surely the molecule; part is the structure around it, the daily attention, the tracking, the quiet, profound experience of actively tending to one’s own mind. I find that combination genuinely compelling, and the unknowns are part of what makes this such an interesting moment to be practicing medicine.
Why this fits how I think about healing
What moves me most about ketamine isn’t the pharmacology. It’s what it implies. For years I’ve believed that the body and brain hold a deeper capacity for repair than we give them credit for, that healing is often less about forcing a system and more about creating the conditions for it to restore itself. Ketamine, at its best, looks like exactly that: not a chemical that papers over pain, but a key that briefly opens a window, a period of heightened plasticity in which the brain becomes, for a time, more able to change. And in that window, the other work, therapy, reflection, connection, the slow human labor of getting better, can finally take root.
That’s why I don’t think of this as a pill you take instead of doing the work. I think of it as something that may make the work possible again for people who had lost access to it. A window, not a shortcut.
A careful frontier
None of this is for everyone, and I hold it with the seriousness it deserves. It isn’t right for people with certain heart, blood-pressure, psychiatric, bladder, or liver conditions, or in pregnancy, and it belongs firmly inside a real medical relationship, with thorough evaluation and close monitoring, never something you order and forget. The frontier is exciting precisely because it has to be walked carefully.
But for the right person, someone who has tried and tried and still feels stuck, I think this is one of the most quietly hopeful developments I’ve come across in my career. We’re watching medicine relearn something it had forgotten: that the brain isn’t a fixed object but a living, changing thing, and that under the right conditions, faster and more fully than we once believed, it can heal.
If you’ve felt stuck for a long time and you’re curious whether this might open a door for you, let’s talk, really talk, in a visit. I’d be honored to think it through with you.
Call our office at 703-866-4144 or schedule a consultation with us.
Best wishes,
Dr. Gajer
